Circassia Group Plc Stock Analysis
| CSSPF Stock | USD 0.92 0.00 0.00% |
Circassia Group Plc holds a debt-to-equity ratio of 0.026. Circassia Group's financial risk is the risk to Circassia Group stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Circassia Group's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Circassia Group's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the OTC Stock is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Circassia OTC Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Circassia Group's stakeholders.
For most companies, including Circassia Group, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Circassia Group Plc, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Circassia Group's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Circassia Group's debt-to-equity ratio measures a OTC Stock's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Circassia Group is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Circassia Group to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Circassia Group is said to be less leveraged. If creditors hold a majority of Circassia Group's assets, the OTC Stock is said to be highly leveraged.
Circassia Group Plc is overvalued with Real Value of 0.77 and Hype Value of 0.92. The main objective of Circassia Group otc analysis is to determine its intrinsic value, which is an estimate of what Circassia Group Plc is worth, separate from its market price. There are two main types of Circassia Group's stock analysis: fundamental analysis and technical analysis.
The Circassia Group otc stock is traded in the USA on OTCGREY Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Circassia Group's ongoing operational relationships across important fundamental and technical indicators.
Circassia |
Circassia OTC Stock Analysis Notes
About 60.0% of the company shares are held by company insiders. The book value of Circassia Group was currently reported as 0.16. The company recorded a loss per share of 0.05. Circassia Group Plc had not issued any dividends in recent years. Circassia Group Plc, a medical device company, focuses on the respiratory diagnostics and monitoring products. Circassia Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom. Circassia Pharmaceutical is traded on OTC Exchange in the United States.The quote for Circassia Group Plc is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Circassia Group Plc please contact the company at 44 1865 405 560 or go to https://www.circassia.com.Circassia Group Plc Investment Alerts
| Circassia Group Plc generated a negative expected return over the last 90 days | |
| Circassia Group Plc has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 27.1 M. Net Loss for the year was (19.4 M) with profit before overhead, payroll, taxes, and interest of 16.3 M. | |
| Circassia Group Plc has accumulated about 11.3 M in cash with (5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 60.0% of the company shares are held by company insiders |
Circassia Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 173.85 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Circassia Group's market, we take the total number of its shares issued and multiply it by Circassia Group's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Circassia Profitablity
Circassia Group's profitability indicators refer to fundamental financial ratios that showcase Circassia Group's ability to generate income relative to its revenue or operating costs. If, let's say, Circassia Group is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Circassia Group's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Circassia Group's profitability requires more research than a typical breakdown of Circassia Group's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (60.52) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (41.33) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $41.33. Technical Drivers
Circassia Group Plc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for zero technical drivers for Circassia Group Plc, which can be compared to its peers.Circassia Group Plc Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Circassia Group middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Circassia Group Plc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Circassia Group Plc Debt to Cash Allocation
Many companies such as Circassia Group, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Circassia Group Plc has accumulated 1.7 M in total debt with debt to equity ratio (D/E) of 0.03, which may suggest the company is not taking enough advantage from borrowing. Circassia Group Plc has a current ratio of 1.53, which is within standard range for the sector. Debt can assist Circassia Group until it has trouble settling it off, either with new capital or with free cash flow. So, Circassia Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Circassia Group Plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Circassia to invest in growth at high rates of return. When we think about Circassia Group's use of debt, we should always consider it together with cash and equity.Circassia Group Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Circassia Group's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Circassia Group, which in turn will lower the firm's financial flexibility.About Circassia OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Circassia Group prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Circassia shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Circassia Group. By using and applying Circassia OTC Stock analysis, traders can create a robust methodology for identifying Circassia entry and exit points for their positions.
Circassia Group Plc, a medical device company, focuses on the respiratory diagnostics and monitoring products. Circassia Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom. Circassia Pharmaceutical is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Circassia Group to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Complementary Tools for Circassia OTC Stock analysis
When running Circassia Group's price analysis, check to measure Circassia Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Circassia Group is operating at the current time. Most of Circassia Group's value examination focuses on studying past and present price action to predict the probability of Circassia Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Circassia Group's price. Additionally, you may evaluate how the addition of Circassia Group to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |